Several metabolic processes tightly regulate growth and biomass accumulation. A highly conserved protein complex containing the target of rapamycin (TOR) kinase is known to integrate intra-and extracellular stimuli controlling nutrient allocation and hence cellular growth. Although several functions of TOR have been described in various heterotrophic eukaryotes, our understanding lags far behind in photosynthetic organisms. In the present investigation, we used the model alga Chlamydomonas reinhardtii to conduct a time-resolved analysis of molecular and physiological features throughout the diurnal cycle after TOR inhibition. Detailed examination of the cell cycle phases revealed that growth is not only repressed by 50%, but also that significant, non-linear delays in the progression can be observed. By using metabolomics analysis, we elucidated that the growth repression was mainly driven by differential carbon partitioning between anabolic and catabolic processes. Accordingly, the time-resolved analysis illustrated that metabolic processes including amino acid-, starch-and triacylglycerol synthesis, as well RNA degradation, were redirected within minutes of TOR inhibition. Here especially the high accumulation of nitrogen-containing compounds indicated that an active TOR kinase controls the carbon to nitrogen balance of the cell, which is responsible for biomass accumulation, growth and cell cycle progression.
INTRODUCTION
The adaptation of cells to diverse environmental conditions requires a tight coordination of a multitude of anabolic and catabolic processes. Such a control can only be achieved if intracellular as well as environmental stimuli are properly sensed by regulatory proteins. In eukaryotic organisms, several of these sensor and control proteins evolved and are therefore highly conserved (Chantranupong et al., 2015) . One of the prominent and conserved nutrient sensing proteins is the Ser/Thr protein kinase target of rapamycin (TOR), which has been described as a major regulatory protein that integrates the sensing of numerous signals to coordinate cellular metabolism and growth (Saxton and Sabatini, 2017) . As indicated by its name, TOR is the target of a molecule named rapamycin, which is a compound with antifungal and immunosuppressive properties that was first isolated in the 1970s from the soil bacterium Strepomyces hygroscopius Vezina et al., 1975) . Due to the broad range of antiproliferative activity, rapamycin immediately became an important tool for studying cell growth and proliferation (Martel et al., 1977; Houchens et al., 1983) . TOR was elucidated as the target of rapamycin in the budding yeast Saccharomyces cerevisiae, where two independent TOR genes were encoded in the genome (Heitman et al., 1991) . The presence of these two genes opened the question of their functions, and led to the discovery of two independent TOR complexes (TORC) in yeast (Loewith et al., 2002) and in mammalian cell cultures (Hara et al., 2002; Kim et al., 2002; Sarbassov et al., 2004) . Both complexes, termed TOR complex 1 (TORC1) and TOR complex 2 (TORC2), were different in their composition, localization and functionality (Betz and Hall, 2013; Saxton and Sabatini, 2017) . While TORC1 emerged as a highly conserved protein complex whose homologs have been identified in all thus far studied eukaryotes, including fungi, mammals, worms, flies, plants and algae (Wullschleger et al., 2006; Soulard et al., 2009; Gonzalez and Hall, 2017) , TORC2 is less conserved and seems to be fully absent in plants (Gaubitz et al., 2016) .
Similar to the structural conservation, the functional understanding of the two complexes was quite different. While TORC1, which was shown to be the rapamycin-sensitive complex, is associated to the control of several anabolic processes, including the synthesis of proteins (Ma and Blenis, 2009) , lipids (Ricoult and Manning, 2013) and nucleotides (Ben-Sahra et al., 2013; Robitaille et al., 2013) , much less was learnt about the functional implications of TORC2 (Gaubitz et al., 2016) .
In contrast to the understanding of the function of TOR signaling in mammals and yeast, the understanding of the function and the targets of TORC1 in photosynthetic organisms has lagged behind (Xiong and Sheen, 2014; Dobrenel et al., 2016a) . One of the main reasons that restricted the structural and mechanistic understanding of the TOR pathway in plants was the insensitivity of most land plants to the TOR inhibitor rapamycin (Menand et al., 2002; Dobrenel et al., 2016a) . Fortunately, several photosynthetic red and green algae, including the model green alga species Chlamydomonas reinhardtii, have been proven to be sensitive to the TOR-inhibiting drug rapamycin (Perez-Perez et al., 2017) and therefore started to pave the way towards functional studies in these photoautotrophic systems. Accordingly, a number of studies have shown that TOR inhibition in Chlamydomonas not only globally affects growth and development (Crespo et al., 2005) , but its function was also shown to negatively control catabolic processes like autophagy (Perez-Perez et al., 2010) , while anabolic processes like protein translation were positively controlled by the active TORC1 (Diaz-Troya et al., 2011) . Still, even though mounting evidence has accumulated that TOR regulates several metabolic pathways in yeast and mammals (Jewell and Guan, 2013; Ricoult and Manning, 2013; Gonzalez and Hall, 2017) , only a few studies have analyzed the impact of TOR inhibition on primary- (Lee do and Fiehn, 2013; Kleessen et al., 2015) or lipid-metabolism (Imamura et al., 2015 (Imamura et al., , 2016 Couso et al., 2016) in Chlamydomonas. Interestingly, for different reasons all of these studies used unsynchronized batch cultures, which were grown in medium supplemented with acetate as an additional carbon source, precluding physiological and photoautotrophic growth of the green model algae.
In the present study, we therefore conducted a systemic study to better understand the physiological and molecular response of Chlamydomonas to pharmacological-induced TOR inhibition. Contrary to all the previous studies, we analyze the influence of rapamycin treatment on cell cycle dynamics, primary-and lipid metabolism, using synchronized cultures, grown under photoautotrophic conditions (Juppner et al., 2017) . In addition to using self-sustaining growth conditions, we also included short-term kinetic sampling throughout the complete diel cell cycle, allowing us to determine the timing and chronology of physiological and molecular changes after TOR repression. Accordingly, we detected massive accumulation of several amino acids within a few minutes, but also differential partitioning of carbon into storage lipids providing a more complete picture of the cell cycle dynamics and metabolomic regulation in this photoautotrophic model system.
RESULTS

Experimental set-up for rapamycin-based inhibition of TOR kinase
Chlamydomonas growth is, in contrast to yeast (Barbet et al., 1996) , not fully arrested by rapamycin treatment (Crespo et al., 2005) . In previous studies, concentrations between 0.1 lM and 10 lM rapamycin were used (Crespo et al., 2005; Kleessen et al., 2015; Couso et al., 2016) , but full inhibition was still not achieved. In order to determine if higher rapamycin concentrations have more complete growth inhibitory effects, a starting population of 5 9 10 5 cells of Chlamydomonas strain CC-1690 (21 gr; Sager, 1955) was grown photoautotrophically in the presence of six different concentrations of rapamycin (0.5, 1, 2, 4, 8 and 16 lM) . After 24 h of unsynchronized growth under constant light, the relative growth rate (cell number) of the inhibited cultures was compared with cultures grown in the presence of equal concentrations of drug vehicle. As can be seen from Figure S1a , growth inhibitory effects of concentrations >2 lM rapamycin start to decrease, but still lead to slightly higher growth inhibition. Accordingly, to obtain the maximal growth repression, we decided to use a working concentration of 5 lM rapamycin for all further experiments.
Because we were planning to use synchronously growing Chlamydomonas cultures, supplemented with light and CO 2 as the only energy and carbon source, for our time-resolved TOR inhibition experiment, we wanted to determine if the rapamycin application time point (TP), namely the cell cycle phase, had an impact on growth and obtained cell numbers. In order to elucidate this influence, synchronized CC-1690 cultures (Juppner et al., 2017) were treated with 5 lM rapamycin at different TPs after the beginning of the diel cell cycle (0, 2.5, 5, 7.5 and 10 h after light was switched on). To determine the impact of rapamycin, the cells were grown until the end of the diel cell cycle and the increase in cell number was determined ( Figure S1b ). As can be seen, the application of the drug at an early stage of the synchronized cell cycle had a greater influence, indicating that even though TOR inhibition repressed growth at every cell cycle phase, the repression was stronger, the earlier the drug was applied.
Taken together, these results indicated that administration of 5 lM rapamycin at the onset of light (beginning of the day) leads to a maximal growth inhibition and therefore to a maximal repression of TOR activity throughout the synchronized diel cell cycle. Accordingly, the experimental design was following a previously described report for the metabolic and cytosolic analysis of synchronized CC-1690 cells (Juppner et al., 2017) . The previously described experiment, where cultures were grown in three independent fermenters, was therefore extended by three additional fermenters, where 5 lM rapamycin were applied at the beginning of the day (light phase). Samples were harvested in duplicates from each of the six independent fermenters at 15 TPs, 0.25, 0.5, 1, 2, 4, 6, 8, 10, 11, 12, 13, 14, 16, 20 and 24 h after the light was switched on and the drug or equal volumes of drug vehicle were added. To monitor the impact of TOR inhibition, several morphological, physiological and molecular parameters were analyzed. The complex experimental design is summarized in Figure 1 .
TOR inhibition results in reduced cell number and changes in the mean cell volume (MCV)
Cell number and MCV were monitored at the above-mentioned 15 TPs throughout the diel cell cycle (Figure 1 ). It can be seen that 5 lM rapamycin treatment reduced the absolute cell number achieved from the 24 h (12 h light/ 12 h dark) growth period by approximately 50% compared with control conditions (Figure 2a ). The reduction in absolute cell number was accompanied by an 11.2% decreased maximum MCV of the rapamycin-treated cells (Figure 2b ). This slight decrease in the MCV of the TORinhibited cultures, and the significant 50% decrease in absolute cell number, implies that the daughter cells (DCs) of the rapamycin-treated culture should have a slightly higher MCV, as less division cycles were carried out from only slightly smaller-sized cells. Accordingly, as predicted from the cell number and the cell size measurements (Figure 2a and b) , a significant 25% increase of the MCV was observed for the rapamycin-treated cultures harvested at TP 20 and 24 (red dotted area in Figure 2b ). In addition to these two differential size phenotypes, related to the biomass accumulation and the cell number, we observed another peculiar size phenotype, which was detected within the first 60 min after rapamycin treatment. Contrary to the two above-mentioned phenotypes, the early size difference was only showing a transient 11% increase starting at 30 min after drug treatment (black dotted area in Figure 2b) . Accordingly, the rapamycin-treated cells maintained this slight, but significantly, increased MCV until 60 min after treatment and, only then, the control cells outgrew the TOR-inhibited cells (Figure 2c ).
The decrease in cell proliferation after rapamycin treatment is explained by a significantly altered cell size distribution
To better understand the differences in cell number and its connection to the MCV, we analyzed the MCV by not only calculating it for the whole range between 0 and 1900 lm 3 , but also by determining the cell population distribution within distinct cell volume size windows. Accordingly, we calculated MCVs within six distinct windows with a step size of 300 lm 3 (Figure 3a -f). The 300-lm 3 step size was based on a previous finding that CC-1690 cells required this critical cell volume to reach the first commitment point (CP; Juppner et al., 2017) . The stepped plotting of the size distributions provided a more refined picture of the differential growth behavior of the treated and control cultures. The decrease of the starting mother cell (MC) population, which had an average volume of 150 lm 3 (Figure 2b ), progressed almost at the same pace for the control and rapamycin-treated cultures in the first 10 h in the light (Figure 3a) . Similarly, the accumulation of cells in the next size range, 300-600 lm 3 , peaked for both control and rapamycin cultures at TP 6 (Figure 3b ). Already in this size population it can be seen that the rapamycin-treated cultures showed a differential size distribution. While the distribution for the control samples showed the maximum at TP 6, the rapamycin-treated cultures showed a bimodal distribution with a local maximum at TP 6 and a second one at TP 13 ( Figure 3b ). These results indicate that light-related growth processes were initiated equally in both cultures during the first few hours, but while the control cells progressed continuously into the next size ranges, by linearly building up biomass, the rapamycin-treated cultures ceased this progress and reached the higher volume ranges much slower. This delay in reaching the maxima for the subsequent size of 600-900 lm 3 and 900-1200 lm 3 is even more pronounced, where the peak apices were reached by the control culture at TPs 8 and 10, while the rapamycin culture required two additional hours (Figure 3c and d) . Interestingly, for the last two size ranges, 1200-1500 lm 3 and 1500-1900 lm 3 , the delay in reaching the maxima was reduced to only 1 h (Figure 3d-f) . Accordingly, we saw that contrary to the result obtained from the overall MCV (Figure 2b) , the growth phase (G1) for the control samples lasted until TP 11 ( Figure 3f) and not, as displayed in Figure 2b , till TP 10. In the case of the rapamycin-treated cultures, the determination of the end of the G1 phase from the step-sized (Figure 3f ) and the overall MCV ( Figure 2b ) were in good agreement, as both show that the treated culture grew until the end of the light phase at TP 12 (Figures 2b and 3f) . Looking in more detail at the relative distributions in the different size windows indicated additionally that the rapamycin-treated cultures not only exhibited a delay in reaching the larger MCV ranges, but also that the cells stayed much longer within these ranges (Figure 3c -e). To illustrate the width of the sojourn time in the different ranges, we plotted the percent distribution of all six size ranges in a single line plot diagram (Figure 3g and h). Here it could be seen that the width of the distribution of the different size ranges was 4-8 h for the control cultures, while it lasted up to 16 h for the rapamycin-treated cells.
In addition to the delay in moving from one size range to the next, it can be seen from the representations in Figure 3 that the control samples not only peaked in the size range of 1500-1900 lm 3 at 11 h, but also that more than twice the number of cells reached this size (Figure 3f-h ). This observed disequilibrium in number of cells in the largest cell size range, which represents the population that potentially divides into 16 or more DCs, therefore explains the massive 50% difference in absolute cell number (Figure 2a) , even though the overall MCV was decreased only by~12% ( Figure 2b ).
Finally, yet importantly, the size-range-resolved analysis of the MCV depicts more accurately the appearance of the first DCs, at the beginning of the sporulation phase (Figure 3a, g and h) . Accordingly, we can show that sporulation (Sp) starts at TP 10 in the control cultures, while the first DC release could only be detected after TP 13 in the rapamycin culture (Figure 3a) .
CP, mitosis and sporulation are delayed after rapamycin treatment, while DNA synthesis is not
In a previous study, we determined that the CP of synchronized control CC-1690 cultures occurred 4 h after the onset of light (TP 4) once the cells surpassed a critical cell volume of approximately 300 lm 3 (Juppner et al., 2017) . Having seen that several of the cell size parameters were only slightly decreased until TP 4 (Figures 2a and b , and 3), we asked if the rapamycin-treated cells also reached their CP at the same time and cell size. Interestingly, even though no major changes in the cell size of the different cultures were visible in this 4-6 h time frame (Figure 2b ), we found that the rapamycin-treated cells reached the CP approximately 1 h later compared with the control cells (Figure 4a ). This surprising result indicated that the rapamycin-treated cells required a slightly larger cell size to commit to S/M phase. As indicated in Figure 2b (black line at 5 h), this critical size is close to 380 lm 3 for the TOR-inhibited cultures, which is approximately 27% larger than the critical size of the control sample. In addition to the above-described delayed growth parameters and the reduced cellular size, we also found that the onset of mitosis, as determined by the appearance of initial mitotic furrows (Bisova and Zachleder, 2014) , was delayed upon rapamycin treatment. The first mitotic furrows appeared 2 h later in the rapamycin-treated cells, compared with control (Figures 4b and S2 ). Contrary to the delayed onset of commitment and the delayed initiation of mitosis, the start and timing of DNA synthesis (S-phase), which precedes mitosis, was not delayed in the TOR-inhibited cells (Figure 4c ). Still, as to be expected from the reduced number of offspring produced by the rapamycin-treated cultures, the 50% reduced DNA-content of the TOR-inhibited cells (Figure 4c) clearly conforms to the observed twofold decrease in the production of DCs (Figure 2a) . Strikingly, this reduction without any delay in DNA synthesis might imply that TOR inhibition results in the uncoupling of growth, and cell proliferation.
Taken together, the absence of delay in the synthesis of DNA accompanied by the 1 h delayed CP and the 2 h delayed onset of mitosis do not fully explain the observed 3 h delay in the release of DCs and the 4 h delay in accomplishing the complete cell cycle to reach G0. This result therefore implied that further steps between mitosis and both the onset and termination of sporulation were affecting the length and timing of the individual phases of the entire cell cycle. The timing and duration of the different, cell cycle phases of TOR-inhibited and control cultures were summarized in Figure 5 .
Rapamycin treatment reduces chlorophyll content proportionally to the reduction in cell number
After having shown that rapamycin treatment has a significant impact on diel growth behavior, we considered how the reduction in growth was connected to the molecular composition of the cells. In order to ensure a standardized comparison of control versus rapamycin-treated cultures, it was important to use an accurate and reliable indicator of the actual cell number/biomass for the normalization of our metabolic measurements. This is especially true for Chlamydomonas, as this green alga is following a specific cell division cycle, which is characterized by a multiple fission mechanism, where the G1 phase is extended and followed by multiple, alternating, S/M cycles (Bisova and Zachleder, 2014) . Accordingly, for the 12-h periods during the light phase, cells are not dividing and a cell number equivalent is required to normalize the differently growing cells between the different TPs and different treatments (Figure 1 ). In a previous study, we showed that chlorophyll increases proportionately to the cellular growth and holds 0-300 300-600 600-900 900-1200 1200-1500 1500-1900 as a normalization factor for biomass and cell number (Juppner et al., 2017) . To validate if the same chlorophyll to biomass/cell number proportionality was true for the growth of rapamycin-perturbed CC-1690 cells, we monitored the chlorophyll content throughout the 24 h diel cell cycle and checked if the proportionality was robust under both conditions. As can be seen in Figure S3a , similar to the number of detected DCs, the amount of chlorophyll was not only reduced by approximately 50% after rapamycin treatment, but the timing for the onset of chlorophyll synthesis was highly synchronized between the two treatments. To illustrate this in more detail we made a scatter plot of the chlorophyll concentrations from both treatments and calculated the correlation coefficient.
As can be seen from Figure S3b , the chlorophyll concentrations are highly correlated with a value of 0.97, indicating that the chlorophyll concentration was linearly reduced in the rapamycin-treated cultures, but still following a control-like pattern. To further quantify if the rapamycin treatment changes the chlorophyll content of the cell, the cell number was normalized to the chlorophyll content in samples collected at the beginning (before rapamycin treatment) and the end of the cell cycle (after rapamycin treatment). As expected from the measurement of absolute chlorophyll concentrations ( Figure S3a ), no difference was observed for the amount of chlorophyll to cell number ratio, neither in control nor in the rapamycin-treated cultures ( Figure S3c ). These results therefore confirmed that rapamycin has no quantitative impact on the chlorophyll synthesis timing and concentration per cell and can be used for the reliable normalization of the starch-, primary metabolite-and lipid data from the synchronization experiment.
Repression of the TOR kinase leads to higher levels of stored carbon per cell
In several studies, it has been shown that a reduction in growth is highly correlated to an increased accumulation of starch (Juergens et al., 2016) and triacylglycerols (TAGs; Merchant et al., 2012) . To determine if increased levels of stored carbon also occur after inhibition of TOR, we extracted starch, lipids and primary metabolites from the synchronized cultures and analyzed these compounds and their time-resolved distribution. The two main storage carbon pools, TAGs and starch, clearly follow the expectation that growth and carbon storage are negatively correlated. While we detected a twofold decrease in the cell number of the rapamycin-treated cultures, we measured a twofold increase in starch content at the end of the day (TP 12) in the rapamycin-treated cultures ( Figure 6a ). The relationship between growth and TAGs was not as linear, but the fold change increase of TAGs in rapamycin-treated cultures was, with a value of fourfold at TP 12 and four-sixfold at TP 13 even more pronounced ( Figure 6b ).
The exact twofold increase of starch was quite interesting as, in combination with the twofold reduction in cell number, this result indicates that the absolute CO 2 fixation per volume of culture and its conversion into starch was exactly the same in the control as well as in the rapamycin-treated cultures.
In addition to the two-threefold higher increase of TAGs compared with starch in the rapamycin-treated CC-1690 cells, we also observed that the accumulation of TAGs started significantly earlier after rapamycin inhibition. While TAG levels increase massively in rapamycin-treated cultures between TP 0.5 and 2, the TOR-inhibited cultures only showed a significant accumulation of starch between TP 2 and 6 (Figure 6a and b) . Interestingly, we also detected that even though higher TAGs and starch levels were accumulating, implying that also higher amounts of these compounds were degraded during the night, we detected a proportionally slower degradation rate of these storage compounds at the beginning of the night (Figure 6a and b) . While 20% of the starch was already degraded within the first hour of the dark phase in the control samples, the rapamycin-treated cultures only degraded 10% within the same time ( Figure 6a ). This comparison was a little bit more complicated for the TAG levels, as the control sample showed two peaks at TP 12 and 14, while the rapamycin-treated culture only peaked at TP 13. Nevertheless, the degradation of TAGs after TP 13 was clearly steeper under rapamycin-treated conditions, compared with the degradation observed in the control samples (Figure 6b) . If the second apex in the control and its absence in the TOR-inhibited samples were related to the starch degradation, and hence increased carbon availabilities cannot be answered at this point, but it would be interesting to analyze this phenomenon and its impact on TAGs by using starchless mutants (Zabawinski et al., 2001; Li et al., 2010) . Taken together, our results show that similar to other growth-inhibited photoautotrophic systems, the partitioning of carbon between growth and storage was severely tipped towards the accumulation of storage molecules under TOR-inhibited conditions.
TOR inhibition alters primary metabolism of Chlamydomonas significantly within minutes
To further understand the impact of the rapamycin treatment on primary metabolism of synchronized Chlamydomonas cultures, we used the polar fraction, containing the primary metabolites (Table S1 ), according to a previously described extraction protocol (Juppner et al., 2017) . To obtain an overview of the changes in the metabolic composition throughout the cell cycle, we started our analysis by performing a principal component analysis (PCA). Interestingly, the PCA data allowed for a complete separation of each TP from the two growth conditions ( Figure S4a) . Surprisingly, even though the basic separation between the two treatments was obtained, both datasets show a similar data trajectory within the PCA plot.
After having shown that the two experimental conditions were fully separated from each other in the PCA, we aimed to simplify the representation of the individual datasets. For this purpose, we additionally performed the PCA on the individual treatments ( Figure S4b and c) . These plots showed a more distinct cyclic behavior, resembling an imperfect circle, compared with the integrated PCA of the whole dataset. The loophole of the open circle points out that the samples taken at the beginning of the day (TP 0.25) were already significantly different from the later samples taken at the end of the night (TP 24). The difference between these two TPs is 15 min, and accordingly we can conclude that 15 min of light was sufficient to change the global composition of the primary metabolites under both experimental conditions ( Figure S4b and c) . In addition to the major shift between TP 0.25 and 24 under both conditions, there were also clear differences in the trajectories between the two treatments. While the samples of TP 0.25-8 were almost equidistantly spaced in the control samples (Figure S4b) , the same TPs of the rapamycin samples were more divergent ( Figure S4c ). For example, TP 0.5 and 1 clustered together in the rapamycin samples, while they were more distinct under control conditions ( Figure S4b) . Similarly, the measurements from TP 8 of the rapamycin treatment showed a clear deviation from the cyclic path ( Figure S4c ), indicating a major metabolic shift occurred here. Surprisingly, none of these observed deviating TPs seems to be directly associated to TPs described as transitions in the cell cycle scheme ( Figure 5 ).
To better understand the individual metabolic impact producing these global PCA patterns, we looked at the contribution plot of all the control versus the rapamycintreated samples. This contribution plot, which summarizes the impact of individual metabolites in discriminating the two selected sample groups, clearly illustrates that almost all of the 62 analyzed primary metabolites were increased in the rapamycin cultures, while only a few measured metabolites were higher in the control samples ( Figure S5 ). Taken together, this result are in full agreement with the results obtained from the analysis of storage carbon (Figure 6) , indicating that the reduction in growth not only leads to an accumulation of storage compounds, but also to increased concentrations of precursor compounds that can be used for cellular anabolism.
A different carbon partitioning can be observed between day and night after TOR inhibition Carbon storage and primary metabolites were clearly elevated in the growth-repressed rapamycin cultures; in the next step, we therefore compared the time-resolved concentration of the individual primary metabolites (Table S1 ). As we saw from Figure S5 , many, but not all, metabolites were increased after rapamycin treatment. In Figure 7 , the main inputs into the daily starch production were plotted side by side with the primary products of the starch degradation, produced in the dark. Here it can be seen that in accordance with the daily increased starch production in the rapamycin-treated cultures, the pool size of the contributing hexose phosphates, derived from carbon fixation within the Calvin-Benson-Basham (CBB) cycle (Johnson and Alric, 2013) , were more depleted under TOR-inhibited conditions (Figure 7 ). During the night phase, the hexose phosphate concentrations were significantly higher, especially in the early-to mid-night , where the rapamycin-treated cultures accumulated larger pool sizes of these sugar phosphates. This result might be explained by the fact that the rapamycin-treated cultures were breaking down more than double the amount of stored carbon. The same is true for the direct breakdown products of starch, so we found isomaltose, maltotriose, maltose and glucose significantly elevated throughout the whole night (Figure 7) . Interestingly, the fold change between the amount of degraded starch and breakdown intermediates did not fully reflect this proportion, indicating that these primary breakdown products were further processed and converted into other not detected compounds or secreted from the cell.
An additional observation came from the time-resolved analysis of isomaltotriose. This compound, which is associated with starch degradation, was not only higher at the beginning of the night, when net starch degradation was increasing, but it was also significantly higher during the day (Figure 7 ). This observation indicated that the rapamycin-treated cells, which significantly increase their storage carbon pools, not only synthesize starch in the light, but also started to partially degrade it at the same time. the comparison of the two curves of starch and isomaltotriose, it can be seen that the degradation product (isomaltotriose) accumulated even faster than the storage product (starch). Similar, but not as pronounced, was the increased accumulation of maltotriose and maltose during the day, while the glucose pool seems to be more or less unchanged between the two treatments. Contrary to the consistent and systemic differences in the day-and night-behavior upstream and downstream of starch metabolism, the pool sizes of intermediates from glycolysis and tricarboxylic acid (TCA) cycle showed a more variable pattern between control and the rapamycintreated cells. We could detect a clear day and night inversion of the intensities of 2-phosphoglycerate (2-PGA) between rapamycin and control samples ( Figure S6) . Accordingly, the levels for this metabolite were higher in the control cultures during the day, while being higher in rapamycin cultures during the night. Surprisingly this pattern was not correlated to the diel signatures upstream or downstream of 2-PGA. Correspondingly, we found almost no changes in the distribution between control and rapamycin samples for 3-phosphoglycerate (3-PGA), while dihydroxyacetoneophosphate (DHAP) had a very distinct increase between TP 10 and 14 in the control samples (Figure S6) . The metabolic signature of phosphoenolpyruvate (PEP), which is downstream of 2-PGA, was to some extent similar to the pattern of its substrate, as it was significantly higher in the control, but the night distribution of PEP showed no significant differences between the two growth conditions. Similarly, the four TCA cycle intermediates citrate, succinate, fumarate and malate did not show consistent differences between the control and rapamycin treatments. The only exception to this oscillating and interconverting behavior of the glycolytic and TCA cycle intermediates was observed for the diel patterns of pyruvate and 2-oxoglutarate. Both metabolites, which were considered branching points in the metabolic pathways (Johnson and Alric, 2013) , were significantly upregulated in the rapamycin-treated cultures ( Figure S6 ), indicating that there was either a higher flux into these compounds or a decreased flux out of their pools.
Nitrogen-containing metabolite pool sizes were substantially increased upon rapamycin treatment
In agreement with the increased concentration of the 2-oxoglutarate pool ( Figure S6 ), it can be seen that all of the 18 detected proteinogenic amino acids were substantially upregulated across the 24-h cell cycle in the rapamycintreated cultures (Figure 8 ). Even though all amino acids, next to the synthesis intermediate homoserine and the downstream products 2-aminobutyrate, ornithine, citrulline, putrescine and spermidine, were multifold upregulated throughout the whole cell cycle, the three aromatic amino acids phenylalanine, tyrosine and tryptophan, next to the sulfur-containing amino acid methionine, exhibited significantly lower fold upshifts (Figure 8 ). The upregulation of amino acids, next to the different amplitudes observed throughout the populations of amino acid, followed a handful of different patterns. While some amino acids were equally concentrated in the control and in the rapamycin-treated cultures at the beginning of the day, others were already several-fold increased within 15 min of rapamycin treatment. Here especially, glutamate and glutamine, which are the main nitrogen assimilation amino acids derived from 2-oxoglutarate, were immediately and substantially increased after TOR-inhibition (Figure 8 ). In addition to the speed and amplitude these amino acids increase, they still displayed a difference in their accumulation pattern during the day. While the vast majority of the detected amino acids showed an immediate, steep or delayed increase of concentration in the rapamycin-treated cultures during the light phase, some amino acids show a continuous, linear decrease at the end of the day. Nevertheless, some amino acids including Asp, Asn, His, Thr, Ile and Arg did not follow this pattern, but instead showed an abrupt, several-fold drop once the light was switched off (Figure 8 ). This indicates that there was a strict dependence on light-driven carbon-skeletons from the CBB cycle, for the pronounced over-accumulation of these amino acids.
Surprisingly, compared with the high increase for the detected proteinogenic and the non-proteinogenic amino acids, some polyamines, including putrescine and spermidine, showed only moderate or no increase after rapamycin treatment (Figure 8 ). These results indicated that especially glutamate seemed to be continuously interconverted to these polyamines and that this interconversion somehow was fueled into a significantly increased pool size of arginine, without fueling the downstream products (Figure 8) .
In addition to the diverse amino acids, which over-accumulated in the rapamycin-treated cultures, we inspected the composition of the other large pool of nitrogen-containing compounds, namely the nucleic acids. In our GC-MS measurements, we were able to detect and profile the two nucleotides AMP and GMP, and the four nucleobases adenine, guanine, hypoxanthine and uracil (Figure 9) .
The pool size of the two purine nucleotides was almost unchanged throughout the cell cycles between control and rapamycin treatment, while all the different nucleobases were significantly increased after TOR-inhibition. Here especially the purine bases guanine and hypoxanthine were immediately severely upregulated after rapamycin treatment, while the third purine, adenine, only showed a moderate increase (Figure 9a ). The pyrimidine base uracil, which is an RNA-specific nucleobase, also showed a significant, but more oscillatory increase in the rapamycin-treated cultures (Figure 9b ). Hypoxanthine, which is a primary (Figure 9a ), was not only the most severely increased nucleobase, but it was also the nucleobase with the fastest induction kinetics. Accordingly, the hypoxanthine levels already increased 30 min after the rapamycin treatment by several-fold. A similar trend of severe and fast upregulation in the rapamycin-treated cultures was noticed for the primary degradation product of uracil, b-alanine (Figure 9b ).
Lipidomic analysis reveals minor but significant changes in the composition of structural lipids
Having observed massive changes in the composition of the storage carbon, especially the storage lipids, we wondered if the other lipid classes were also affected after rapamycin treatment. To obtain an overview of the data, we calculated PCA of all lipid species after having removed the diurnally regulated TAGs. This global analysis showed, contrary to the result obtained from the PCA of the primary metabolites, that the lipid data were not as distinct between the rapamycin and the control samples. While the PCA of the primary metabolites separated the two conditions from the first to the last TP ( Figure S4 ), the PCA of the lipid data was more convoluted between the two treatments ( Figure S7) . Accordingly, the rapamycin and the control sample hardly separated within the first 6 h of treatment ( Figure S7a ). From TP 8 onwards a clearer separation was observed, but still the samples were much more similar to each other, compared with the distinction obtained from the primary metabolites.
Due to the major convolution of the two treatments in the PCA in Figure S7a , we decided to perform PCAs of the individual treatments to improve the visualization of the subsequent intra-data relationships of the time-resolved data ( Figure S7b and c) . Based on these plots, clear differences between the two treatments could be observed. While the PCA of the control samples showed a more open, U-shaped, trajectory of the sampled 15 TPs (Figure S7b) , the rapamycin-treated cells almost completely closed the cycle and came back to their origin ( Figure S7c) . This was surprising, as we expected a major impact of TOR-inhibition on cellular lipidomic composition, but the result seems to indicate that the TOR-inhibited cultures returned to a similar lipidomic state that resembled the conditions from the start of the cycle. If this is explained by the lower growth rate of the TOR-repressed cells or simply a statistical artifact remains to be determined.
To validate the PCA results further, we comparatively analyzed the class-wise behavior of the lipids derived from the rapamycin-treated cells against the control samples. For this purpose, the sum of all lipids from each of the nine detected lipid classes was calculated and plotted AE the standard error. As we have seen from the PCA plot in Figure S7a, the intensities of the individual lipid classes show smaller differences, especially during the day, compared with the massive changes observed for some primary metabolites (Figures 6 and 10) . Nevertheless, there were clear differences detectable between the different lipid classes after rapamycin treatment. Accordingly, we detected that all three major glycolipids classes (Li-Beisson et al., 2015) , monogalactosyldiacylglycerols (MGDGs), digalactosyldiacylglycerols (DGDGs) and sulfoquinovosyldiacylglycerols (SQDGs), which can be regarded as the major membrane-forming lipids in the chloroplast, were significantly upregulated after rapamycin treatment. Interestingly, all three of the plastidic lipid classes were not immediately higher in the rapamycin cultures, as we could detect slightly higher concentrations in the control samples at the beginning (TP 0.25-2) of the cell cycle (Figure 10 ). This result was a little bit surprising, as it indicated that the control cultures could more efficiently build up new plastidic membranes once the light was switched on but, then, after 2-4 h the rapamycin cultures started to surpass the control samples and accumulated higher concentrations of lipids in the plastid per cell until the end of the night (Figure 10) .
A similar pattern was observed for the main endomembrane lipid classes, the diacylglyceryltrimethylhomoserine (DGTS), which are betaine lipids (Benning et al., 1995; LiBeisson et al., 2015) , and the phosphatidylethanolamines (PEs). The DGTS showed an intermediate accumulation pattern compared with the DGDGs and the MGDGs, and accumulated to higher concentrations in the rapamycintreated cultures between TP 4 and 6. The PEs were even more delayed in the accumulation in the rapamycin-treated cultures, reaching higher concentrations only between TP 6 and 8 (Figure 10 ).
Contrary to these consistent changes of the main plastidic and endomembrane lipids, only minor changes were observed for the phospholipids of the phosphatidylglycerol (PG) or the diacyclglycerols (DAG) and the free fatty acids (FA; Figure 10 ).
DISCUSSION TOR inhibition decreases growth and biomass accumulation leading to reduced cell numbers in Chlamydomonas
The most obvious phenotype of the rapamycin treatment was characterized by a 50% reduction in the total cell number (Figure 2a ). This incomplete repression of cell growth was in full agreement with previous studies elucidating the function of TOR in Chlamydomonas (Crespo et al., 2005; Lee do and Fiehn, 2013; Kleessen et al., 2015; Couso et al., 2016) . Part of the explanation for the incomplete growth repression was traced back to the fact that the native FKBP12 (FK506 binding protein 12 kDa) protein in Chlamydomonas does not effectively bind rapamycin (Crespo et al., 2005) . The sensitivity of the Chlamydomonas FKBP12 protein to the drug could be increased by two point mutations but, still, contrary to the yeast system, where rapamycin treatment leads to a full growth arrest in G1 (Barbet et al., 1996) , Chlamydomonas cells were not fully inhibited in growth (Crespo et al., 2005) . To overcome, at least in part, this problem, we increased the rapamycin concentration by 10-fold to 5 lM, to make sure that we obtained maximal inhibition of the TOR complex (Figure S1) .
In previous studies it has been shown that the number of DCs produced by a single MC depends on the obtained size of the MC during the G1 phase, before transiting to the rapidly alternating S/M phases (Craigie and CavalierSmith, 1982; Cross and Umen, 2015) . Accordingly, it was not surprising that the decreased cell number of the rapamycin-treated cells was accompanied by an 11% decrease of the maximally obtained MCV of the cells (Figure 2b ). To explain this observation of reduced MCV of the TOR-inhibited cultures, we envisioned two possible scenarios: either the distribution of the cells within the rapamycin-treated population was highly heterogeneous, with significant proportions of cells at different sizes, leading to the observed decreased MCV; or the cell size distribution between the rapamycin and the control cells was highly similar, with the only difference that the cells from the rapamycin-treated cultures simply do not reach the same proportion of large cells as the control cultures. To answer this question, we plotted the segmented cell size distribution of the timeresolved measurements of the MCV of the rapamycin and the control cultures (Figure 3) . Interestingly, the result showed that both explanations contribute to the decreased MCV. On the one hand the proportion of maximally large The dark phase is indicated as gray background. Samples are represented as mean AE standard error (n = 6). Abbreviations: ACP, acyl carrier protein; CDP-DAG, cytidine diphosphate diacylglycerol; DAG, diacylglycerol; DGDG, digalactosyldiacylglycerol; DGTS, diacylglyceryltrimethylhomoserine; DHAP, dihydroxyacetonephosphate; FA, fatty acid; G-3-P, glyceraldehyde-3-phosphate; MAG, monoacylglycerol; Met, methionine; MGDG, monogalactosyldiacylglycerol; PA, phosphatidicacid; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PGP, phosphatidylglycerolphosphate; Ser, serine; SQDG, sulfoquinovosyldiacylglycerol; TAG, triacylglycerol; UDP-Gal, uridine diphosphate galactose; UDP-Glc, uridine diphosphate glucose; UDP-SQ, uridine diphosphate sulfoquinovose.
© (Figure 3f ) was clearly higher in the control cultures, but additionally the measured MCV was also affected by the homogeneity and shape of the size distribution of the treated cultures within each cell size window. While the transitions from one cell size range to the next showed a sharp and almost Gaussian distribution for the control samples (Figure 3b-f) , the distribution of the rapamycintreated cells either showed strong tailing (Figure 3c-e) or even a bimodal distribution (Figure 3b ). This result indicated that the cells were possibly not only growing less absolutely, but also that they were not responding similarly to the TOR-inhibition. The basis for such diversity might be in part explained by the non-negligible cell-to-cell diversity, which can be observed even in highly synchronous Chlamydomonas cultures (Garz et al., 2012) . This observed heterogeneity of the cell population therefore results from either a differential growth response or a differential sensitivity to the TOR-inhibiting drug. To answer this question, it would be interesting to collect cells from the different size populations within each culture and TP, and determine the degree of TOR activity and the metabolic composition.
CP and DC size were slightly altered, while the timing of the S-phase was not affected at all by the inhibition of TOR
In addition to the slightly decreased MCV and heavily decreased cell number, we observed that it took the rapamycin-treated cells on average 2 h longer to obtain their maximal MCV (Figure 2b ). This was surprising, as it showed that inhibition of TOR not only decreased the absolute accumulation of cellular mass, but also significantly shifted the different cell cycle phases, including the onset of mitosis (Figure 4b ) and the initiation of DC release during sporulation (Figures 2a and 3a ; Bisova and Zachleder, 2014) . In this regard, it was surprising to see that the absolute growth, in this case the MCV, was not altered between the control and rapamycin-treated cells during the first 4 h of the cell cycle in the light (Figures 2b and 3a) . Similarly, the onset of another essential cell cycle phase, the S-phase, when DNA synthesis starts, was also not delayed (Figure 4c) . This observation was even more puzzling due to the fact that the commitment to cell division, which was expected to be controlled by the size of the cells (Oldenhof et al., 2007) , was shifted from TP 4 in the control cells to TP 5 in the rapamycin-treated cells (Figure 4a ). Because the cells at TP 4 were still of equal size between the two treatments, this observation implied that a different measure was determined by the cell, controlling the onset of commitment. One common controller of cell size and DNA content, namely the retinoblastoma (RB) protein, which has been shown to be a negative regulator of the cell cycle and a positive regulator of cellular growth in Chlamydomonas, but also all other higher eukaryotes (Fang et al., 2006) , therefore seems to be unaffected by the rapamycin treatment. Accordingly, an alternative 'sizer' has to be active, leading to the delayed and shifted onset of commitment, mitosis and sporulation ( Figure 5 ). In budding yeast, it has been reported that the cells determined their maturity to commitment by measuring the overall translation rate, and that even cells larger than the critical cell volume did not commit to division if a critical translation rate was not achieved (Unger and Hartwell, 1976; Jorgensen and Tyers, 2004) . This might therefore be part of the regulatory circuit controlling commitment in Chlamydomonas too, especially as it has been shown previously that rapamycin treatment significantly decreased the translation rate in Chlamydomonas (Diaz-Troya et al., 2011).
As mentioned above, contrary to the delay in CP and mitosis, we did not observe a delay in the timing of synthesis of DNA, though a clear reduction (~50%) in the overall DNA content per population. This reduction is therefore in full agreement with the 50% reduction of cell number, indicating that the synthesis and DNA content per cell is not changed (Figure 4c ). Interestingly, these results are contrary to results obtained from rapamycin-treated Arabidopsis seedlings, where the DNA synthesis, in the root meristem, was completely arrested after TOR inhibition (Xiong et al., 2013) . If these results are reflecting the differences between the photoautotrophic character of the Chlamydomonas cultures and the heterotrophic character of the Arabidopsis root system, remains to be elucidated.
Repression of growth was accompanied by a differential partitioning of carbon into growth-related processes and storage reserves
As we have discussed in the previous sections, it seems that TOR, similar to observations in yeast (Barbet et al., 1996) , does not have a direct control over the cell cycle but instead controls anabolism and cellular growth, which then partially affect the cell cycle progression. One of the essential functions controlling biomass accumulation in photoautotrophic organisms is their readiness to allocate resources to growth or utilize these resources for storage purposes. Under photoautotrophic conditions, with CO 2 as the sole carbon source, the synthesis of starch is an efficient way to store carbon during the light phase (Johnson and Alric, 2013) . After starch, neutral, non-membraneforming lipids such as TAGs represent a major storage for highly reduced carbon and energy (Johnson and Alric, 2013) . Accordingly, measurement of the accumulation of carbon storage reserves, in the form of starch and TAGs, provides direct insight into the growth tendencies of a photoautotrophic cell (Sulpice et al., 2009) the day), but also an increased consumption (during the night) of both storage reserve compounds. These results were therefore in full agreement with results from yeast (Barbet et al., 1996; Schmelzle et al., 2004) , fruit fly (Teleman et al., 2005; Bjedov et al., 2010) and Arabidopsis (Caldana et al., 2013) . Still, the novelty of our data was that we recorded for the first time the dynamics of the accumulation of starch and TAGs throughout the diel cycle in a TOR-repressed system, which provides insight into the timing and the metabolic regulation of these processes. Therefore, we could see that the abundance in the accumulation of TAGs was not only significantly higher, but that the dynamics were also faster (Figure 2a and b) . These results were rather unexpected, as it had been shown in Chlamydomonas cells, which were subjected to nitrogen starvation, that the TAG accumulation usually lags behind that of starch. Accordingly, it was reported that rapid TAG synthesis occurs only when carbon supply exceeds the capacity of starch synthesis (Derrien et al., 2012) . Additionally, we could clearly show that starch accumulation in TOR-inhibited cultures was accompanied by a decrease of phosphorylated carbohydrates, i.e. glucose-6-phosphate (G6P), fructose-6-phosphate (F6P), mannose-6-phosphate and ribose-5-phosphate (ribose-5P), during the light phase and an increase during the dark phase (Figure 7 ; Table S1 ). These results were therefore not only in agreement with previous observations from unsynchronized Chlamydomonas cultures after TOR inhibition (Lee do and Fiehn, 2013) or data obtained from artificial micro-RNA lines of TOR in Arabidopsis (Caldana et al., 2013) , but also showed that the timing of the accumulation of starch directly impacts on the decrease of the hexose-phosphate pools.
Similar to the direct precursor to product relationship of the starch synthesis, we could show that there seems to be a significant degree of starch breakdown during the day, indicated by the accumulation of isomaltotriose during the light phase (Figure 7 ). This observation might imply that the initially fixed carbon of the starch might also be required for additional processes, and therefore the equilibrium between synthesis and breakdown is partially tilted in the rapamycin-treated cultures.
The significantly increased concentrations of TAGs mainly comprise the polyunsaturated species (≥ 4 double bonds) with 52-56 carbons in their three fatty acids (Table S2 ). This result was in agreement with results from TOR inhibition in Arabidopsis (Caldana et al., 2013) and in Chlamydomonas (Imamura et al., 2016) . Furthermore, we found that 15 min of rapamycin treatment led to reduced levels of unsaturated (≤ 3 double bonds) TAG species with 46-50 carbons in their three fatty acids. This might imply that after TOR inhibition, TAG species with short-chain fatty acids were mobilized during the initial growth phase to provide precursors for the rapid synthesis of TAGs with longerchain fatty acids. The early increase of storage lipids was accompanied by a reduction of several membrane lipid species during the first 4 h after rapamycin treatment (Figure 10) . These results indicate that during the initial growth phase a breakdown of membrane lipids, as well as TAGs with short-chain fatty acids, fuels the rapid synthesis of TAGs by shuffling fatty acids from membrane lipids to TAGs. The remodeling of membrane lipids to TAGs under nitrogen starvation has been proposed in several publications (Fan et al., 2012; Li et al., 2012a; Sakurai et al., 2014) . Moreover, it has been shown that a lipase-encoding gene (CrLIP1) was required for rapid TAG turnover in Chlamydomonas (Li et al., 2012a) , which could be associated with the observed lipid remodeling upon TOR inhibition.
Another possible explanation for the higher and faster accumulation of TAGs might come from the observation that TAGs were not only derived by the re-editing of fatty acids from structural lipids into TAGs (Li et al., 2012b) , but were instead actively driven by the activation of de novo fatty acid synthesis (Imamura et al., 2015) . This result is especially interesting, as it would not only place TOR upstream of another essential anabolic process, but it might also explain the observed switch in the accumulation pattern of TAGs. In a previously published study, it was shown that, contrary to the common accumulation of TAGs in lipid droplets in the cytosol, Chlamydomonas cells under nitrogen stress also tended to accumulate TAGs in the chloroplast (Fan et al., 2011) , the subcellular location of fatty acid synthesis. However, the role of TOR in the regulation of biosynthesis of different lipid classes in Chlamydomonas has yet to be explored in detail.
TOR repression leads to major reprogramming of primary metabolism, shifting the carbon to nitrogen balance Inhibition of TORC1 in mammals has been shown to lead to prompt downregulation of anabolic processes, including protein Blenis, 2009), nucleotide (Ben-Sahra and Manning, 2017) and lipid biosynthesis (Ricoult and Manning, 2013) , while catabolic processes, including autophagy (Russell et al., 2014) and proteolysis (Zhao et al., 2015) , were massively increased. Both repression of anabolism next to induction of catabolism lead to high energy and nutrient economy, which in turn lead to decreased growth and accumulation of metabolic precursors. The accumulation of biosynthetic precursors, for example, sugar phosphates, amino acids or nucleotides, can be explained by the reduced synthesis of complex structural biomolecules like proteins, polynucleotides (DNA, RNA) or lipids.
Interestingly, we could show that concentrations of structural lipid (Figure 10 ) and DNA ( Figure 4c) were, if at all, increasing in the TOR-inhibited Chlamydomonas cells, indicating that the biosynthetic or degradation pathways controlling the synthesis or catabolism of these compounds were not significantly changed in the rapamycin-treated cultures. Contrary to the absolute DNA content, our data showed that rapamycin treatment results in a massive increase in hypoxanthine, guanine and b-alanine. Guanine and hypoxanthine are degradation products of purine nucleotides, which can serve for the regeneration of nucleotide pools, while b-alanine is a degradation product of the pyrimidine nucleotide uracil (Figure 9a and b ; Zrenner et al., 2006) . The source for the accumulation of nucleotide degradation products might originate from degradation of RNAs. This assumption was supported by the observation that rapamycin treatment of transgenic Arabidopsis lines expressing yeast FKBP12 resulted in a strong reduction in the total RNA content (Ren et al., 2012) . Whether this assumption was also valid in Chlamydomonas needs to be validated. As de novo synthesis of nucleotides is very energy consuming, the increase of guanine and hypoxanthine could also indicate an increase of the salvage pathway to provide sufficient nucleotides for DNA synthesis and transcription. In yeast, rapamycin treatment leads to a downregulation of transcripts of purine biosynthesis (Shamji et al., 2000) . Furthermore, it has been shown that mTOR regulates the de novo pyrimidine synthesis through S6K1 by posttranslational regulation of CAD (carbamoyl-phosphate synthetase2, aspartate transcarbamoylase, dihydroorotatase; Ben-Sahra et al., 2013) . From the current data it was not possible to determine whether strong accumulation of guanine and hypoxanthine results from an increased degradation or an increased purine salvage. It is likely that a combination of both leads to the obtained accumulation of guanine and hypoxanthine.
Similarly to the increase of nucleotide breakdown products, we detected a massive and extremely rapid (within 15 min of rapamycin treatment) increase of almost all amino acids (Figure 8 ). Such a fast and coordinated accumulation of amino acids has not as yet been shown in any photoautotrophic system, confirming the immediate response of Chlamydomonas to the rapamycin-based TOR inhibition. The accumulation of amino acids could be partially explained by the expected decreased translation and thereby a decrease of amino acid incorporation into newly synthesized proteins. This prediction matches results from mammalian studies, showing that translation inhibitor treatments with cycloheximide lead to significant accumulations of free amino acids (Beugnet et al., 2003) . The assumption that translation is significantly inhibited in Chlamydomonas but also in plants is confirmed by several studies showing that the incorporation of heavy isotopelabeled amino acids into newly synthesized proteins (Ahn et al., 2011; Diaz-Troya et al., 2011) but also polysomal loading (Deprost et al., 2007; Sormani et al., 2007) is massively decreased after TOR inhibition. Similarly, it was shown that the synthesis of rRNA and ribosomal proteins was significantly reduced in Arabidopsis (Ren et al., 2012; Dobrenel et al., 2016b) , indicating that not only the translation elongation (Ma and Blenis, 2009 ) but also the potential to assemble intact ribosomes is massively reduced. Here especially the repression of rRNA fits also to the abovementioned increase of nucleotide breakdown products.
In addition to the repressed protein synthesis machinery, also the induction of autophagy, namely the induction of catabolic degradation of proteins could explain the increased amounts of free amino acids. The induction of autophagy after TOR inhibition was clearly elaborated in mammals and yeast (Russell et al., 2014) , but also in Arabidopsis (Liu and Bassham, 2010; Pu et al., 2017) and Chlamydomonas (Perez-Perez et al., 2010) , providing an additional mechanism explaining the metabolic phenotype. The only discrepancy between the immediate amino acid response and the repression of translation and induction of autophagy after TOR repression within hours after TOR repression (Perez-Perez et al., 2010; Diaz-Troya et al., 2011) is the timing. This massive difference implies that there might be additional mechanisms contributing to the fast amino acid accumulation.
A possible explanation for the observed discrepancy could be derived from the link of the observed degradation of RNA (Figure 9 ) and the necessity to fix the released NH 4 in stably non-toxic intermediates, like amino acids, but also polyamines. While the proteinogenic amino acids accumulated immediately after rapamycin treatment (Figure 8 ), we noticed that polyamines especially the diamine putrescine, which can be derived from both arginine and ornithine, continuously increased after TP 6 after TOR-inhibition, when the amino acid pools are maximally filled. Putrescine can be further converted into the triamine spermidine by the addition of an aminopropyl group derived from decarboxylated S-adenosylmethionine (Kusano et al., 2008) . With a delay of 2 h, spermidine accumulated from TP 8 onwards after rapamycin treatment. Interestingly, as well as being nitrogen-storing compounds, polyamines were also considered critical for regulation of cellular growth and cell division in eukaryotic and prokaryotic organisms (Kusano et al., 2008; Takahashi and Kakehi, 2010) . In Chlamydomonas, it has been shown that a decrease in the spermidine level during the G1 phase by either addition of spermine or inhibition of spermidine synthase prevented cell division (Theiss et al., 2002) , further coupling the observed decrease of spermidine during the G1 phase to delayed mitosis and DC release ( Figure 5 ).
Taken together, it can be concluded that TOR inhibition in Chlamydomonas leads to global changes in the central metabolism resulting in differential carbon partitioning and altered C/N balance, which are accompanied by decreased growth, delayed cell cycle and increased storage reserves accumulation. Considering this metabolic alteration, it can be inferred that the carbon deployment to anabolic processes was strictly reduced upon TOR inhibition, while the carbon fixation into starch and TAGs was increased.
In future metabolomics, but possibly also proteomic and phosphoproteomics analysis, using synchronized Chlamydomonas cultures, we might be able (by using immediate -within minutes -dynamic sampling) to more precisely elucidate the kinetics of TOR-regulated processes and therefore distinguish these from pleiotropic changes.
EXPERIMENTAL PROCEDURES
Synchronization of Chlamydomonas liquid cultures in fermenters
Chlamydomonas reinhardtii cells of the strain wild-type CC-1690 mt+ were stored and preserved on solid TAP or HSM plates (Harris, 2009 ).
Experiments were started from pre-cultures by taking cells from solid plates and transferring them to sterile HS medium (Harris, 2009) . Pre-cultures were grown on a rotary shaker at 24°C at 100 lE m À2 sec À1 continuous light. Cells were grown to a cell density of 5 9 10 6 cells mL
À1
. For the synchronization, a custom-made fermenter system (Glasbl€ aserei M€ uller, Berlin, Germany) was used. Each fermenter consists of a double-walled glass vessel, which is connected to a recirculating cooler to maintain constant temperature, while a stable CO 2 concentration of 2% (v/v) is maintained by bubbling in CO 2 -enriched air ( Figure S1 ).
To initiate synchronization, a pre-culture was added to the fermenter in HSM medium giving a density of 1 9 10 6 cells mL
. Synchronization was achieved by growing the culture under 12:12 h light-dark regime at 200 lmoles m À2 sec À1 (Lumilux Cool white, 30W/840, Osram, Germany) and a constant temperature of 34°C. At the end of each 24 h cycle, the culture was re-diluted to 1 9 10 6 cells mL À1 with fresh HSM medium. After four rounds of light-dark cycles, synchrony of cultures was obtained and experiments were conducted.
Rapamycin treatment of synchronized Chlamydomonas cultures
For the determination of a suitable growth inhibitory concentration, various dilutions of rapamycin, re-suspended in ethanol, were applied to liquid cultures. As an efficiency readout, we determined changes in cell number after 24 h of treatment ( Figure S1a) . Once an optimal growth inhibitory concentration was determined, we next assessed a TP where administration of rapamycin would lead to maximal growth inhibition. For this purpose, synchronized cultures were treated either with 5 lM rapamycin or the equal amount of drug vehicle at 0 h (onset of light), 2.5 h, 5 h, 7.5 h and 10 h after the start of the light phase ( Figure S1b ). For the final experimental setup (described below), a final concentration of 5 lM rapamycin was applied to each of the fermenters, while similar concentrations of drug vehicle were added to the control cultures for the comparison.
Experimental design
Synchronized cultures were grown in three fermenters as described in Juppner et al. (2017) for each of the two experimental conditions, namely control and rapamycin. Two samples were collected from each fermenter per TP, making a total of 3*2 replicates per treatment and TP (Figure 1) . The samples were collected at 15 different TPs across the 24 h diurnal cell cycle, including samples at 0. 25, 0.5, 1, 2, 4, 6, 8, 10, 11, 12, 13, 14, 16, 20 and 24 h. Cells were distributed to collection tubes or Eppendorf tubes and pelleted by centrifugation for 5 min. The supernatant was discarded and the cell pellet was snap-frozen in liquid nitrogen and stored at À80°C until further analysis (Juppner et al., 2017) .
Determination of cell cycle parameters
Cell number and MCV were determined with a Z2 Coulter Particle Counter a (Beckman Coulter), using a size range between 30 and 1900 lm 3 . DNA was extracted using the CTAB method as described previously (Doyle and Doyle, 1987; ) . The mitotic state and CP were determined as described previously (Umen and Goodenough, 2001; Oldenhof et al., 2007) .
Extraction of chlorophyll, lipids and primary metabolites
Primary metabolites, chlorophyll and lipids were extracted with minor changes as described elsewhere (Salem et al., 2016) . Snap-frozen cell pellets, harvested by centrifugation from 10-50 9 10 6 cells, were re-suspended in 1 mL of pre-cooled (À20°C) methyl tert-butyl ether (MTBE)-extraction buffer [methanol: methyl tert-butyl-ether (1 : 3; v/v) mixture; Biosolve, the Netherlands] containing internal standards as mentioned previously (Salem et al., 2016) .
The resuspended cell pellets were immediately mixed before ultrasonification in an ice-cooled water bath for 10 min. Then the samples were incubated for 1 h on an orbital shaker at 4°C. To induce the liquid : liquid-phase separation, 650 lL of UPLC-grade methanol : water (1 : 3; v : v; Biosolve, the Netherlands) was added to the homogenate and mixed, before centrifuging at 20 000 g for 5 min at 4°C in a table top centrifuge. The addition of the methanol : water mixture resulted in a separation of an upper MTBE-phase, containing lipids and chlorophyll, and a lower phase, containing the polar and semi-polar metabolites, next to a solid pellet in the bottom of the Eppendorf tube. The solid pellet contains the precipitated proteins next to starch and other insoluble polymers, such as cell wall fragments (Salem et al., 2016) .
For further analysis, 500 lL of the MTBE-phase and 650 lL of the lower, aqueous-phase were transferred to fresh 1.5-mL Eppendorf tubes. If samples were supposed to be analyzed immediately they were dried in a SpeedVac and re-suspended in the proper resuspension buffer. If the samples should be stored for days to weeks, the lipid-phases can be kept as aliquots from the MTBE extraction at À20°C. The polar aliquots were dried in a SpeedVac concentrator before storing the pellets at À80°C. The solid pellet was frozen in liquid nitrogen and stored at À80°C until further extraction. To measure the impact of contaminations from the extraction process, the whole extraction procedure was additionally performed with two-four empty, sample-free, Eppendorf tubes (method blank).
Determination of polar metabolites using GC-MS
For the analysis of the samples, the dried pellets were derivatized and analyzed using a previously described GC-TOF-MS method (Krall et al., 2009) . All chromatograms were processed using the Pegasus ChromaTOF software, while retention index calculation was based on the FAMEs, and peak annotations were performed using msmatch software (Krall et al., 2009; Krueger et al., 2011) . For the compound, annotation of the exported spectra was compared with spectra derived from authentic chemical standards. For the quantitative comparison, the peak height of at least one unique mass was extracted from the spectrum. This value together with the matching factor for each compound was exported as an Excel-file. At the end of the analysis procedure all compounds were manually validated to remove ambiguous assignments and to maintain high-quality peak annotations.
Determination of lipids
The dried pellets were re-suspended in a volume of 300 lL of a mixture of acetonitrile : isopropanol (7 : 3; Biosolve, the Netherlands), before processing as described previously (Hummel et al., 2011; Salem et al., 2016) . Chromatograms were further processed using Excalibur software version 2.30 (Thermo-Fisher) and Progenesis CoMet software (Version 2.4; Nonlinear, Newcastle upon Tyne, UK). Peaks were annotated according to their accurate mass and their systematic, lipid class-specific retention time (Hummel et al., 2011) . For some lipid species, more than one peak was detected having the same m/z and identical adducts but different retention times. In these cases, we named the lipid species with the letters A, B, C, D, depending on their elution order.
Determination of the chlorophyll content
To determine the chlorophyll content, 100 lL of the MTBE-phase was mixed 1 : 10 (v : v) with 90% methanol and measured using an UV-VIS spectrometer at wavelengths of 665 nm and 652 nm to distinguish between chlorophyll a and chlorophyll b. The chlorophyll a, b and total content were determined using the equations described by Bar-Nun (Bar-Nun and Ohad, 1980) .
Extraction and determination of starch content, protein concentration and quality
For determination of total protein and starch content, the solid pellet was extracted in a two-step procedure as described in detail previously (Salem et al., 2016; Juppner et al., 2017) .
Filtering and normalization of the metabolomics and lipidomic raw data
To remove the noise and contaminants from the data, three filtering criteria were applied. The first filter concerns contaminants. Therefore, every metabolite or lipid, whose average peak height was lower than the average peak height of the method blanks, was removed from data. In a second step, metabolites or lipids for which 50% of the values were below 500 (primary metabolite) or 1000 (lipids) arbitrary counts, respectively, were removed from the data. Third, metabolites or lipids that had more than one TP with more than 50% missing values were removed.
To compare the relative concentration of metabolites under different growth stages, it is necessary to normalize the data to the same amount of cells. For this purpose, normalization was done to the extraction volume (metabolites per mL), followed by a normalization to the internal standards [1,2-diheptadecanoyl-sn-glycero-3-phosphocholine as a standard for lipid normalization and (U-13C) sorbitol for the polar metabolites analyzed by GC-MS; Hummel et al., 2011; Salem et al., 2016] . In a final step, metabolite intensities were normalized to the chlorophyll content of each extracted sample.
Statistical data analysis
Data were analyzed using Excel (Microsoft, Redmond, USA). PCA was performed using SIMCA (Umetrics, Umea, Sweden).
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